We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.

Necessary Cookies Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics Cookies

We would like to set Google Analytics cookies to help us analyse the traffic on our website.

Acino at a Glance

Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, Ukraine and Eurasian countries, and Latin America.

We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing.

Join us in shaping the future of healthcare.

  • $0m

    Group sales for full-year 2024

  • 0%

    Sales in emerging markets

  • 0

    Employees (at the end of 2024)

Advancing with Arcera

Acino is part of Arcera, a global company in the life sciences sector headquartered in Abu Dhabi, United Arab Emirates.

Arcera was established by ADQ, an Abu Dhabi-based investment and holding company, to build a global life sciences powerhouse poised to make significant contributions to realising the UAE’s aspiration to emerge as a frontrunner in science and technology.

To learn more about Arcera, please visit www.arceralifesciences.com.

Leadership Team

Isabel Afonso

Chief Executive Officer of Arcera

Acino is part of Arcera, a global company in the life sciences sector headquartered in Abu Dhabi, United Arab Emirates. To learn more about Arcera, please visit www.arceralifesciences.com.

Computer science engineer, Minho University, Portugal

General management program, INSEAD, Paris and Singapore

Executive education programs at IMD business school in Switzerland, Wharton and Harvard business school in the USA

  • 2023

    Chief Executive Officer of Arcera

  • 2022-23

    International Head of In-Market Brands & Business Innovation at Novartis

  • 2021-22

    General Manager China at Novartis Oncology

  • 2020-21

    Chief Commercial Officer at Performance Health

  • 2018-21

    Managing Director and International Head eCommerce / Digital at Performance Health

  • 2016-18

    Head of Global Commercial Operations and Executive Committee Member at Sandoz

  • 2015-18

    Head of Global Commercial Strategy and Executive Committee Member at Sandoz

  • 2014-15

    Cluster Head BACH (Belgium, Austria and Switzerland at Sandoz

  • 2011-15

    Country Head at Sandoz

  • 2007-11

    Country Head
    Global Head of BA Productivity
    Global head of HR IT
    at Novartis Consumer Health

Christina Peusch

Chief Legal Officer

Eugene Zaika

Head of Ukraine and Eurasian countries

Mansoor Meenai

Head of Middle East, Türkiye and Africa

Andrés García Baquero

Head of Latin America

John Norman

Head of Africa

Board of Directors

Isabel Afonso

Chairwoman of the Board of Acino since June 2024

Andrew Crossley

Member of the Board

Ingrid Eberle

Member of the Board